PERSONALISED ANTIPLATELET TREATMENT STRATEGY AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI (PASTOR STUDY)

Verify Now platelet function testing was performed the following morning. 46 patients were found to be clopidogrel non-responders according to platelet reactivity measurements (cut-off PRU>235) and were treated with novel ADP inhibitors (44 with prasugrel, 4 with ticgarelor).

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2015-03, Vol.65 (10), p.A241-A241
Main Authors: Mikkelsson, Jussi, Paana, Tuomas, Lepantalo, Aino, Karjalainen, Pasi
Format: Article
Language:English
Subjects:
Cardiology
Cardiovascular
Drug therapy
Internal Medicine
Medical research
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Verify Now platelet function testing was performed the following morning. 46 patients were found to be clopidogrel non-responders according to platelet reactivity measurements (cut-off PRU>235) and were treated with novel ADP inhibitors (44 with prasugrel, 4 with ticgarelor).
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(15)60241-8